Skip to main content
SpringerLink
Log in

Pharmakologie von Prokinetika

  • Conference paper
Motilitätsstörungen im oberen Gastrointestinaltrakt

Zusammenfassung

Die Häufigkeit der Behandlung von Übelkeit und Erbrechen als Folge von Krankheitszuständen, die mit gastrointestinalen Motilitätsstörungen einhergehen, steigt ständig (Reynolds 1989). Im folgenden soll die pharmakologische Wirkungsweise und die klinische Anwendung einiger bekannter Verbindungen dargestellt werden. Darüber hinaus soll ein Einblick in die Zusammenhänge von Motilitätsstörungen und Übelkeit bzw. Erbrechen gegeben werden. Schließlich sollen Ergebnisse von pharmakologischen Neuentwicklungen dargestellt werden, die selektiver gegenüber Motilitätsstörungen einerseits und gegen starke Übelkeit und Emesis andererseits eingesetzt werden können.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Akwari DE (1983) The gastrointestinal tract in chemotherapy — induced emesis, a final common pathway. Drugs [Suppl 1] 25:18–34

    Article  PubMed  CAS  Google Scholar 

  • Andrews PLR, Davies CJ, Maskell L (1990) The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can J Physiol Pharmacol 68:325–345

    Article  PubMed  CAS  Google Scholar 

  • Anker L, Lauterwein H, Waterbeemd H van de, Testa B (1984) 79. NMR conformational study of aminoalkylbenzamides, aminoalkyl-o-anisamides, and metoclopramide, a dopamine receptor antagonist. Helv Chim Acta 67:706–716

    Article  CAS  Google Scholar 

  • Aono T, Shioji T, Kinugasa T, Onishi T, Kurachi K (1978) Clinical and endocrinological analysis of patients with galactorrhea and menstrual disorders due to sulpiride or metoclopramide. J Clin Endocrinol Metab 47:675–680

    Article  PubMed  CAS  Google Scholar 

  • arznei-telegramm (1990) Nebenwirkungen Cisaprid (Alimix, Propulsin) und ZNS. arznei-telegramm 5/90:49

    Google Scholar 

  • Basurto C, Roila F, Del Favero A, Ballatori E, Minotti V, Tonato M (1988) A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy. Cancer Invest 6:475–479

    Article  PubMed  CAS  Google Scholar 

  • Bateman DN (1983) Clinical pharmacokinetics of metoclopramide. Clin Pharmacokinet 8:523–529

    Article  PubMed  CAS  Google Scholar 

  • Bateman DN, Darling WM, Boys R, Rawlings MD (1989) Extrapyramidal reactions to metoclopramide and prochlorperazine. Q J Med 71 264:307–311

    PubMed  CAS  Google Scholar 

  • Berkowitz DM, McCallum RW (1980) Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 27:414–420

    Article  PubMed  CAS  Google Scholar 

  • Bleiberg H, Gerard B, Dalesio O, Crespeigne N, Rosenczeig M (1988) Activity of a new antiemetic agent: alizapride. A randomized double-blind crossover controlled trial. Cancer Chemother Pharmacol 22:316–320

    Article  PubMed  CAS  Google Scholar 

  • Borison HL, McCarty LE (1983) Neuropharmacology of chemotherapy — induced emesis. Drugs [Suppl 1] 25:8–17

    Article  PubMed  CAS  Google Scholar 

  • Borison HL, Wang SC (1953) Physiology and pharmacology of vomiting. Pharmacol Rev 5:193–230

    PubMed  CAS  Google Scholar 

  • Bradbury AJ, Gunning SJ, Naylor RJ, Tan CCW (1985) Drug actions of serotonin mechanisms can enhance field stimulation — induced contractions of stomach smooth muscle. Br J Pharmacol [Suppl] 86:738 P

    Google Scholar 

  • Brockmann P, Pelties W (1985) Bewährungsprobe von retardiertem Metoclopramid bei chronischen Motilitätsstörungen des Magen-Darm-Traktes. Therapiewoche 35:1007–1012

    Google Scholar 

  • Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 24:360–400

    Article  PubMed  CAS  Google Scholar 

  • Buchheit KH, Bertholet A (1990) Analysis of the stimulatory effect of some benzamides in small intestinal motility. Naunyn Schmiedebergs Arch Pharmacol (Suppl) 341:R88

    Google Scholar 

  • Buchheit KH, Engel G, Mutschier E, Richardson B (1985a) Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum. Evidence for two distinct release mechanisms. Naunyn Schmiedebergs Arch Pharmacol 329:36–41

    Article  PubMed  CAS  Google Scholar 

  • Buchheit KH, Costali B, Engel G, Gunning SJ, Naylor RJ, Richardson BP (1985b) 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205–930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in-vivo. J Pharm Pharmacol 37:664–667

    Article  PubMed  CAS  Google Scholar 

  • Carpenter DO (1990) Neural mechanisms of emesis. Can J Physiol Pharmacol 68:230–236

    Article  PubMed  CAS  Google Scholar 

  • Cesario M, Pascard C, ElMoukhtari M, Jung L (1981) Structure cristalline du metoclopramide et etudes des relations structureactivite. Eur J Med Chem 16:13–17

    CAS  Google Scholar 

  • Champion MC (1988) Minireview domperidone. Gen Pharmacol 19:499–505

    Article  PubMed  CAS  Google Scholar 

  • Christensen J (1988) The enteric nervous system. In: Kumar D, Gustavsson S (eds) An illustrated guide to gastrointestinal motility. Wiley, Chichester New York Brisbane Toronto Singapore, pp 9–31

    Google Scholar 

  • Cilag GmbH (1990) Dosierungskarte zu Alimix. Cilag GmbH, Sulzbach/Taunus, Stand Juli 1990

    Google Scholar 

  • Cisapride Meeting (1986) First international cisapride investigators meeting. Digestion 34:137–160

    Article  Google Scholar 

  • Clark CR, Garcia-Roura LE (1989) Liquid chromatographic studies on the equeous solution conformation of substituted benzamide drug models. J Chromatogr Sci 27:111–117

    PubMed  CAS  Google Scholar 

  • Clarke DE, Craig DA, Fozard JR (1989) The 5-HT4 receptor: naughty, but nice. Trends Pharmacol Sci 10:385–386

    Article  PubMed  CAS  Google Scholar 

  • Cosentino F, Prato A, Laudani A, Percolla S, Franco S, Veroux PF, Imme A (1989) Alizapride versus placebo in premedication in esophagogastroduodenoscopy. Double-blind clinical study. Experimental research in vitro. Minerva Dietol Gastroenterol 35:35–37

    PubMed  CAS  Google Scholar 

  • Costa M, Furness JB (1979) The sites of action of 5-hydroxytrypamine in nerve-muscle preparations from guinea-pig small intestine and colon. Br J Pharmacol 65:237–248

    PubMed  CAS  Google Scholar 

  • Costa M, Furness JB, Llewellyn-Smith IJ (1987) Histochemistry of the enteric nervous system. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, pp 1–40

    Google Scholar 

  • Costali B, Gunning SJ, Naylor RJ, Tyers MB (1987) The effect of GR 38032 F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig. Br J Pharmacol 91:263–264

    Google Scholar 

  • Craig DA, Clarke DE (1990) Pharmacological characterisation of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytrypt-amine4 receptor. J Pharmacol Exp Ther 252:1378–1386

    PubMed  CAS  Google Scholar 

  • Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficay of ondansetron (Gr 38032 F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810–816

    Article  PubMed  CAS  Google Scholar 

  • Daniel EE (1982) Pharmacology of adrenergic, cholinergic, and drugs acting on other receptors in gastrointestinal muscle. In: Bertaccini G (ed) Mediators and drugs in gastrointestinal motility. Springer, Berlin Heidelberg New York Tokyo (Handbook of experimental pharmacology, vol 59/II, pp 248–322)

    Google Scholar 

  • Decktor DL, Pendleton RG, Elnitsky AT, Jenkins AM, McDowell AP (1988) Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-346, 718, on gastric emptying in the rat. Eur J Pharmacol 147:313–316

    Article  PubMed  CAS  Google Scholar 

  • Dhasmana KM, Banerjee AK, Zhu YN, Erdmann W, Parmar SS, Salzman SK (1989) Role of dopamine receptors in gastrointestinal motility. Res Commun Chem Pathol Pharmacol 64:485–488

    PubMed  CAS  Google Scholar 

  • Domperidone review (1979) Postgrad Med J [Suppl] 55:1–54

    Google Scholar 

  • Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 340:403–410

    Article  PubMed  CAS  Google Scholar 

  • El Tyar N, Waterbeemd H van de, Testa B (1985) Lipophilicity measurements of protonated basic compounds by reversed-phase high-performance liquid chromatography. II. Procedure for the determination of a lipophilic index measured by reversed-phase high-performance liquid chromatography. J Chromatogr 320:305–312

    Article  Google Scholar 

  • Fernandez AG, Massingham R (1985) Minireview: Peripheral receptor populations, involved in the regulation of gastrointestinal motility and the pharmacological actions of metoclopramide-like drugs. Life Sci 36:1–44

    Article  PubMed  CAS  Google Scholar 

  • Frigo GM, Lecchinin S, Marcoli M, D’Angelo L, Crema A (1984) Changes in sensitivity to the inhibitory effects of adrenergic agonists on intestinal motor activity after chronic sympathetic denervation. Naunyn Schmiedebergs Arch Pharmacol 325:145–152

    Article  PubMed  CAS  Google Scholar 

  • Furness JB, Costa M (1982) Identification of gastrointestinal neurotransmitters. In: Bertaccini EG (ed) Mediators and drugs in gastrointestinal motility. Springer, Berlin Heidelberg New York Tokyo (Handbook of experimental pharmacology, vol 59/I, pp 383–462)

    Google Scholar 

  • Görich R, Weihrauch TR, Kilbinger H (1982) THe inhibition by dopamine of cholinergic transmission in the isolated guinea-pig. Mediation through alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 318:308–312

    Article  PubMed  Google Scholar 

  • Gunning SJ, Naylor RJ (1985) 5-Hydroxytryptamine can antagonize the ability of metoclopramide and SCH23390 to enhance electrical field stimulation-evoked contractions of guinea-pig isolated stomach muscle. J Pharm Pharmacol 37:78–80

    Article  PubMed  CAS  Google Scholar 

  • Gunning SJ, Naylor RJ, Tattersall FD (1986) The actions of metoclopramide and ICS 205–930 on the guinea pig ileum are dependent on the type of preparation used. Br J Pharmacol [Suppl] 88:373 P

    Google Scholar 

  • Hall H, Ögren SO, Florvall L (1984) Effect of lipophilicity of substituted benzamides on the dopaminergis effects in vivo and in vitro. Acta Pharmacol Toxicol 55:211–215

    Article  CAS  Google Scholar 

  • Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC (1983) Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs 25:451–494

    Article  PubMed  CAS  Google Scholar 

  • Hay AM, Man WK (1979) Effect of metoclopramide on guinea pig stomach. Critical dependence on intrinsic stores of acetylcholine. Gastroenterology 76:492–496

    PubMed  CAS  Google Scholar 

  • Hellenbrecht D, Sailer R (1986) Dose-response relationships of the objective and subjective and antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis. Arzneimittelforschung 36:1845–1849

    PubMed  CAS  Google Scholar 

  • Hellstern A, Hellenbrecht D, Saller R et al. (1987) Absolute bioavailability of metoclopramide given orrally or by enema in patients with normal liver function or with cirrhosis of the liver. Arzneimittelforschung 37:733–736

    PubMed  CAS  Google Scholar 

  • Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB (1989) 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97:447–455

    Google Scholar 

  • Holloway RH, Downton J, Mitchell B, Dent J (1989) Effect of cisapride on postprandial gastro-oesophageal reflux. Gut 30:1187–1193

    Article  PubMed  CAS  Google Scholar 

  • Houin G, Bree F, Tillment JP (1982) Pharmacocinetique et biodisponinbilité de l’alizapride chez l’homme. Sem Hop Paris 58:339–344

    PubMed  CAS  Google Scholar 

  • Houin G, Barre J, Tillement JP (1984) Absolute intramuscular, oral and rectal bioavailability of alzapride. J Pharm Sci 73:1450–1453

    Article  PubMed  CAS  Google Scholar 

  • Huys J, Troch M, Bourguignon RP, Smets P (1985) High-dose alizaptride versus high-dose domperidone: a double-blind comparative study in the management of cis-platinum-induced emesis. Curr Med Res Opin 9:400–406

    Article  PubMed  CAS  Google Scholar 

  • Ireland SJ, Tyers MB (1987) Pharmacological characterization of 5-hydroxytrypamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol 90:229–238

    PubMed  CAS  Google Scholar 

  • Janssen GmbH Deutschland (1989) Kurzinformation zur Anwendung von Cisaprid. Janssen, Neuss, S 1–5

    Google Scholar 

  • Janssen Pharmaceutica AG (1985) Einführung von Motilium-Supp. 60 mg anstelle von Motilium Ampullen. Janssen, Neuss

    Google Scholar 

  • Janssens J, Peeters DL, Vantrappen G, Tack J, Urban JL, DeRoo M, Muls E, Bouillon R (1990) Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. New Engl J Med 322:1028–1031

    Article  PubMed  CAS  Google Scholar 

  • Jenner P, Marsden CD (1979) The substituted benzamides — a novel class of dopamine antagonists. Life Sci 25:479–486

    Article  PubMed  CAS  Google Scholar 

  • Joss RA, Galeazzi RL, Bischoff AK, Brunner KW (1985) Alizapride, a new substituted benzamide, as an antiemetic during cancer chemotherapy. Eur J Clin Pharmacol 27:721–725

    Article  PubMed  CAS  Google Scholar 

  • Joss RA, Galeazzi RL, Bischoff AK, Pirovino M, Ryssel HJ, Brunner KW (1986) The antiemetic activity of high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind study. Clin Pharmacol Ther 39:619–624

    Article  PubMed  CAS  Google Scholar 

  • Jovanović-Mićić D, Samardzić R, Beleslin DB (1989) Pharmacological characteristics of vomiting produced by dopamine. Eur J Clin Pharmacol [Suppl] 36:A214

    Google Scholar 

  • Kilbinger H, Nafzinger M (1985) Two types of neuronal muscarine receptors modulating acetylcholine release from guinea-pig myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 328:304–309

    Article  PubMed  CAS  Google Scholar 

  • Kilbinger H, Pfeuffer-Friederich I (1985) Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus. Br J Pharmacol 85:529–539

    PubMed  CAS  Google Scholar 

  • Kilbinger H, Kruel R, Pfeuffer-Friederich I, Wessler I (1982) The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum. Naunyn Schmiedebergs Arch Pharmacol 319:231–238

    Article  PubMed  CAS  Google Scholar 

  • Koelz HR (1989) Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. Scand J Gastroenterol [Suppl 156] 24:25–36

    Article  Google Scholar 

  • Kusunoki M, Taniyama K, Tanaka C (1985) Dopamine regulation of (3H) acetylcholine release from guinea-pig stomach. J Pharmacol Exp Ther 234:713–719

    PubMed  CAS  Google Scholar 

  • Laduron PM, Leysen JE (1979) Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28:2161–2165

    Article  PubMed  CAS  Google Scholar 

  • Lewis DJ, Coote JH (1990) The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic neurones in the rat, in vivo. Br J Pharmacol 99:667–672

    PubMed  CAS  Google Scholar 

  • Malagelada JR (1984) Potential pharmacological approaches to management of gut motility disorders. Scand J Gastroenterol [Suppl 96] 19:111–126

    Google Scholar 

  • Marzio K, Neri M, Pieramico O, DelleDonne M, Peeter TL, Cuccorullo F (1990) Dopamine interrupts gastrointestinal fed motility pattern in humans. Effect on motilin and somatostatin blood levels. Dig Dis Sci 35:327–332

    Article  PubMed  CAS  Google Scholar 

  • McCallum RW, Fink SM, Lerner E, Berkowitz DM (1983) Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology 84:1573–1577

    PubMed  CAS  Google Scholar 

  • McCallum RW, Prakash C, Campoli-Richards DM, Goa KL (1988) Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 36:652–681

    Article  PubMed  CAS  Google Scholar 

  • Mei N (1983) Recent studies on intestinal vagal afferent innervation. Functional implications. J Auton Nerv Syst 9:199–206

    Article  PubMed  CAS  Google Scholar 

  • Meuldermans W, Peer A van, Hendrichx H et al. (1988) Excretion and biotransformation of cisapride in dogs and humans after oral administration. Drug Metab Dispos 16:403–409

    PubMed  CAS  Google Scholar 

  • Meyboom RHB, Huijbers WAR (1988) Acute extrapiramidale bewegingsstoornissen bij jonge kinderen en bij volwassenen tijdens het gebruik von domperidon. Ned Tijdschr Geneeskd 132:1981–1983

    PubMed  CAS  Google Scholar 

  • Minami H, McCallum RW (1984) The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 86:1592–1610

    PubMed  CAS  Google Scholar 

  • Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497–499

    PubMed  CAS  Google Scholar 

  • Mistiaen W, Hee R van, Blockx P, Hubens A (1990) Gastric emptying for solids in patients with duodenal ulcer before and after highly selective vagotomy. Dig Dis Sci 35:310–316

    Article  PubMed  CAS  Google Scholar 

  • Moss HE, Sanger GJ (1987) Antagonism by BRL43694 of the pseudoaffective reflex induced by duodenal distension. Br J Pharmacol [Suppl] 92:531 P

    Google Scholar 

  • North RA, Henderson G, Katayama Y, Johnson SM (1980) Electrophysiological evidence for presynaptic inhibition of acetylcholine release by 5-hydroxytryptamine in the enteric nervous system. Neuroscience 5:581–586

    Article  PubMed  CAS  Google Scholar 

  • Nueten JM van, Schuurkes JAJ (1989) 5-HT3-serotonergic mechanisms and stimulation of gastrointestinal motility by cisapride. Br J Pharmacol [Suppl] 96:331 P

    Google Scholar 

  • Okwuasaba FK, Hamilton JT (1976) The effect of metoclopramide on intestinal muscle responses and the peristaltic reflex in vitro. Can J Physiol Pharmacol 54:393–404

    Article  PubMed  CAS  Google Scholar 

  • Oliveira CR, Lima MCP, Carvalho CAM, Leysen JE, Carvalho AP (1989) Partition coefficients of dopamine antagonists in brain membranes and liposomes. Biochem Pharmacol 38:2113–2120

    Article  PubMed  CAS  Google Scholar 

  • Ormsbee HS, Fondacaro JD (1985) Minireview. Action of serotonin on the gastrointestinal tract. Proc Soc Exp Biol Med 178:333–338

    PubMed  CAS  Google Scholar 

  • Pandit SK, Kothary SP, Pandit UA, Randel G, Levy L (1989) Dose-response study of droperidol and metoclopramide as antiemetics for outpatient anesthesia. Anesth Analg 68:798–802

    Article  PubMed  CAS  Google Scholar 

  • Pfeuffer-Friederich I, Kilbinger H (1984) Facilitation and inhibition by 5-hydroxytryptamine and R51619 of acetylcholine release from guinea pig myentric plexus. In: Roman C (ed) Gastroentestinal motility. MTP Press, Lancester Boston The Hague Dordrecht, pp 527–534

    Google Scholar 

  • Pinder RM, Brogden RM, Sawyer PR, Speight TM, Avery GS (1976) Metoclopramide. A review of its pharmacological properties and clinical use. Drugs 12:81–131

    Article  PubMed  CAS  Google Scholar 

  • Rand MJ, McCulloch MW, Story DF (1980) Catecholamine receptors on nerve terminals. In: Szekeres L (ed) Adrenergic activators and inhibitors. Springer, Berlin Heidelberg New York Tokyo (Handbook of experimental pharmacology, vol 54/1, pp 223–266)

    Chapter  Google Scholar 

  • Read NW, Houghton LA (1989) Physiology of gastric emptying and pathophysiology of gastroparesis. Gastroenterol Clin North Am 1812:359–373

    Google Scholar 

  • Reynolds JC (1989) Prokinetic agents: a key in the future of gastroenterology. Gastroenterol Clin North Am 18:437–457

    PubMed  CAS  Google Scholar 

  • Reyntjens A, Verlinden M, DeCoster R et al. (1984) Clinical pharmacological evidence for cisapride’s lack of antidopaminergic or direct cholinergic properties. Curr Ther Res 36:1045–1052

    Google Scholar 

  • Robertson DRC, Renwick AG, Wood ND et al. (1990) The influence of levodopa on gastric emptying in man. Br J Clin Pharmacol 29:47–53

    PubMed  CAS  Google Scholar 

  • Sailer R, Hellenbrecht D (1985 a) Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplating-induced emesis. Cancer Treat Rep 69:1301–1303

    Google Scholar 

  • Sailer R, Hellenbrecht D (1985 b) Nutzen und Risiko von hochdosiertem Metoclopramid im Vergleich zu hochdosiertem Haloperidol oder Triflupromazin bei cisplin-induziertem Erbrechen. Klin Wochenschr 63:428–432

    Article  Google Scholar 

  • Salier R, Hellenbrecht D (1986) High dose of metoclopramide or droperidol in the prevention of cisplatin-induced emesis. Eur J Cancer Clin Oncol 22:1199–1203

    Article  Google Scholar 

  • Salier R, Hellenbrecht D, Briemann L et al. (1985 a) Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis. Clin Pharmacol Ther 37: 43–47

    Article  Google Scholar 

  • Sailer R, Hellenbrecht D, Hellstern A, Hess H (1985 b) Improved benefit/risk ratio of higher-dose metoclopramide therapy during cisplatin-induced emesis. Eur J Clin Pharmacol 29:311–312

    Article  Google Scholar 

  • Sailer R, Hellenbrecht D, Bühring M, Hess H (1986) Enhancement of the antiemetic action of metoclopramide against cisplatin-induced emesis by transdermal electrical nerve stimulation. J Clin Pharmacol 26:115–119

    Google Scholar 

  • Sanger GJ (1985 a) The effect of various pharmacological agents on the metoclopramide — induced increase in cholinergic mediated contractions of rat isolated forestomach. Eur J Pharmacol 114:139–145

    Article  PubMed  CAS  Google Scholar 

  • Sanger GJ (1985 b) Effects of metoclopramide and domperidone on cholinergically mediated contractions of human isolated stomach muscle. J Pharm Pharmacol 37:661–664

    Article  PubMed  CAS  Google Scholar 

  • Sanger GJ (1990) New antiemetic drugs. Can J Physiol 68:314–324

    Article  CAS  Google Scholar 

  • Sanger GJ, King FD (1988) From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists. Drug Design Delivery 3:273–295

    CAS  Google Scholar 

  • Sanger GJ, Nelson DR (1989) Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL43694 (granisetron). Eur J Pharmacol 159:113–124

    Article  PubMed  CAS  Google Scholar 

  • Schade RR, Dugas MC, Lhotsky DM, Gavaler JS, Thiel DH van (1985) Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 30:10–15

    Article  PubMed  CAS  Google Scholar 

  • Schemann M, Ehrlein HJ (1986) 5-Hydroxytryptophan and cisapride stimulate propulsive jejunal motility and transit of chyme in dogs. Digestion 34:229–235

    Article  PubMed  CAS  Google Scholar 

  • Schuurkes JAJ, Nueten JM van (1984) Domperidone improves myogenically transmitted an-troduodenal coordination by blocking dopaminergic receptor sites. Scand J Gastroenterol [Suppl 96] 19:101–110

    CAS  Google Scholar 

  • Schuurkes JAJ, Nueten JM van (1985) Evidence against a serotonergic mechanism for the motility stimulating properties of cisapride. Gastroenterology 88:1577–1585

    Google Scholar 

  • Schuurkes JAJ, Nueten JM van, Daele PGH van, Reyntjens AJ, Janssen PAJ (1985) Motor-stimulating properties of cisapride on isolated gastroentestinal preparations of the guinea-pig. J Pharmacol Exp Ther 234:775–783

    PubMed  CAS  Google Scholar 

  • Schwörer H, Racké K (1989) Effects of cisplatin on the release of 5-hydroxytryptamine from guinea-pig small intestine. Involvement of 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol [Suppl] 339:R 96

    Google Scholar 

  • Segrestaa JM, Gueris J, Tiar M (1979) Hyperprolactiemie des antiemetiques-comparaison des quatre produits. Therapy 34:473–475

    Google Scholar 

  • Smith WL, Callahan EM (1988) The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride. J Pharm Pharmacol 40:142–143

    Article  PubMed  CAS  Google Scholar 

  • Staniforth DH (1987) Effect of drugs on oro-ceacal transit time assessed by the lactulose/breath hydrogen method. Eur J Clin Pharmacol 33:55–58

    Article  PubMed  CAS  Google Scholar 

  • Stanley M, Wazer D, Virgilio J, Kuhn CA, Benson DI, Meyerson LR (1983) Lack of potency of metoclopramide’s metabolites in various dopaminergic models. Pharmacol Biochem Behav 18:263–266

    Article  PubMed  CAS  Google Scholar 

  • Taylor WB, Bateman DN (1986) Oral bioavailability of high-dose metoclopramide. Eur J Clin Pharmacol 31:41–44

    Article  PubMed  CAS  Google Scholar 

  • Tolia V, Calhoun J, Kuhns L, Kauffman RE (1989) Randomized, prospective double-blind trial of metoclopramide and placebo for gastroesophageal reflux in infants. J Pediatr 115:141–145

    Article  PubMed  CAS  Google Scholar 

  • Valenzuela JE, Dooley CP (1984) Dopamine antagonists in the upper gastrointestinal tract. Scand J Gastroenterol [Suppl 96] 19:127–136

    CAS  Google Scholar 

  • Vanacker B, Vanaken H (1988) Alizapride in the prevention of postoperative vomiting. A double-blind comparison. Acta Anaesthesiol Belg 39:247–250

    PubMed  CAS  Google Scholar 

  • Wallis D (1981) Minireview. Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci 29:2345–2355

    Article  PubMed  CAS  Google Scholar 

  • Warzee PL, Dive CC (1988) Manometric study of the activity of alizapride on the motor function of the human sphincter of Oddi. J Clin Pharm Ther 13:281–284

    Article  PubMed  CAS  Google Scholar 

  • Willems JL, Lefevre RA (1986) Peripheral nervous pathways involved in nausea and vomiting. In: Davis CJ, Lake-Bakaar GV, Grahame-Smith DG (eds) Nausea and vomiting: mechanisms and treatment. Springer, Berlin Heidelberg New York Tokyo, pp 56–64

    Google Scholar 

  • Wood JD (1987) Physiology of the enteric nervous system. In: Johnson RL (ed) Physiology of the gastrointestinal tract. Raven, New York, pp 67–109

    Google Scholar 

  • Wright MR, Axelson JE, Rurak DW et al. (1988) Effect of hemodialysis on metoclopramide kinetics in patients with severe renal failure. Br J Clin Pharmacol 26:474–477

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. D. Hellenbrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Allgemeines Krankenhaus Celle, Siemensplatz 4, W-3100, Celle, Germany

    Jürgen Hotz (Chefarzt der Gastroenterologischen Abteilung) (Chefarzt der Gastroenterologischen Abteilung)

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hellenbrecht, D. (1990). Pharmakologie von Prokinetika. In: Hotz, J. (eds) Motilitätsstörungen im oberen Gastrointestinaltrakt. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76148-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76148-5_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53274-3

  • Online ISBN: 978-3-642-76148-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation